DHL has announced a US$15 million investment in three Life Science Competence Centers to fulfill what it says is the growing demand for higher levels of quality compliance. Located in Singapore, Mumbai, and Hyderabad, the centres will bolster DHL’s logistics capabilities for the Life Science industry in the region.

The company also announced the launch of the DHL Global Forwarding Aid & Relief Logistics unit in Asia Pacific based in Singapore. Drawing on DHL’s expertise in Life Sciences, DHL Global Forwarding Aid and Relief Logistics focuses on logistics solutions for Humanitarian organisations dealing with sensitive and life critical shipments involved in aid and relief efforts.

“Asia and other emerging markets are a key sourcing, manufacturing and distribution base for the global pharmaceutical industry. Increasingly, they will also be key markets for consumption. Investing in dedicated Life Science Competence Centers enhances our global network as we deliver health for the region and the world,” said Frank Appel, CEO, Deutsche Post DHL.

In 2009, the global pharmaceuticals sector, a key segment of the Life Science industry, is estimated to be worth US$820 billion, with an expected growth rate of 14 -15% in emerging markets.